Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-34,971
Closed -$527K 753
2018
Q4
$527K Sell
34,971
-9,920
-22% -$257K ﹤0.01% 725
2018
Q3
$1.76M Sell
44,891
-2,394
-5% -$108K 0.01% 694
2018
Q2
$2.33M Sell
47,285
-383
-0.8% -$21.7K 0.01% 660
2018
Q1
$2.85M Sell
47,668
-4,538
-9% -$303K 0.02% 637
2017
Q4
$4.11M Sell
52,206
-7,215
-12% -$582K 0.02% 590
2017
Q3
$4.99M Buy
59,421
+460
+0.8% +$32.6K 0.03% 568
2017
Q2
$3.85M Sell
58,961
-100
-0.2% -$6.8K 0.02% 618
2017
Q1
$4.29M Sell
59,061
-3,048
-5% -$200K 0.02% 605
2016
Q4
$3.64M Buy
+62,109
New +$3.28M 0.02% 632

Other funds holding ADNT

Aviva's ADNT Position: Q1 2019 in Review

Aviva sold out of Adient (ADNT) in Q1 2019, closing a stake of 34,971 shares — an estimated $527K sold.

Aviva first reported a position in ADNT in Q4 2016 and held it in 9 quarters. The position peaked at $4.99M in Q3 2017. 353 funds tracked by Wall St. Rank hold ADNT as of Q1 2019.

  • Aviva reported no remaining Adient position as of Q1 2019 after selling out during the quarter.
  • Aviva sold 34,971 Adient shares in Q1 2019, an estimated $527K.
  • Aviva first reported a position in Adient in Q4 2016 and held it in 9 quarters.
  • Aviva's Adient position peaked at $4.99M in Q3 2017.
  • 353 funds tracked by Wall St. Rank held Adient as of Q1 2019.

Based on Aviva's 13F filing for Q1 2019, filed 14 May 2019.